DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
13.26 USD   +0.84%
06/24DECIPHERA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/24DECIPHERA PHARMACEUTICALS, INC.(NASDAQGS : DCPH) added to Russell Microcap Growth Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASDAQGS : DCPH) added to Russell 3000E Growth Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DECIPHERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

01/10/2022 | 07:16am EDT

Item 7.01 Regulation FD Disclosure.

On January 10, 2022, Deciphera Pharmaceuticals, Inc. (the "Company") issued a press release announcing corporate updates and highlighting key 2022 corporate milestones. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.



Exhibit No.                                  Description

99.1                Press Release issued by Deciphera Pharmaceuticals, Inc. on
                  January 10, 2022, furnished herewith

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about DECIPHERA PHARMACEUTICALS, INC.
06/24DECIPHERA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (for..
AQ
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell Microcap Growth Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell 3000E Growth Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell 3000E Value Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell 3000E Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell Microcap Value Index
CI
06/24DECIPHERA PHARMACEUTICALS, INC.(NASD : DCPH) added to Russell Microcap Index
CI
06/16Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
BU
06/16Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Senior Vice President and Ch..
CI
06/02Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
BU
More news
Analyst Recommendations on DECIPHERA PHARMACEUTICALS, INC.
More recommendations